---
title: 'Metastasis-directed stereotactic radiotherapy in patients with breast cancer:
  results of an international multicenter cohort study'
date: '2024-12-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39708074/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241222170843&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Metastasis-directed therapy (MDT) for oligometastatic breast cancer (≤
  5 metastases) has shown little effect in specific scenarios of randomized trials.
  Therefore, we aimed to assess outcomes after metastasis-directed stereotactic radiotherapy
  (SRT) in various clinical scenarios. We conducted an international retrospective
  cohort study in thirteen centers including breast cancer patients receiving SRT
  to any metastatic site. Outcomes included local recurrence (LR), progression-free
  ...
disable_comments: true
---
Metastasis-directed therapy (MDT) for oligometastatic breast cancer (≤ 5 metastases) has shown little effect in specific scenarios of randomized trials. Therefore, we aimed to assess outcomes after metastasis-directed stereotactic radiotherapy (SRT) in various clinical scenarios. We conducted an international retrospective cohort study in thirteen centers including breast cancer patients receiving SRT to any metastatic site. Outcomes included local recurrence (LR), progression-free ...